Healthcare Stocks
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 41 |  INSM Insmed, Inc. | 151.1400 USD | -2.37% | -7.17% | +6.84% | -6.73% | 32.58 B USD | ||
| 42 |  WAT Waters Corp | 322.59 USD | +0.79% | +6.03% | +12.93% | -1.94% | 31.65 B USD | ||
| 43 |  IQV IQVIA Holdings Inc. | 172.52 USD | +3.11% | +0.98% | +2.98% | +15.61% | 29.28 B USD | ||
| 44 |  NTRA Natera, Inc. Common Stock | 201.90 USD | +4.60% | -1.65% | +5.46% | +32.83% | 28.62 B USD | ||
| 45 |  TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 17.8350 USD | -1.46% | -1.90% | -1.52% | +25.73% | 27.78 B USD | ||
| 46 |  PHG KONINKLIJKE PHILIPS N.V. | 28.5250 USD | +0.72% | +5.30% | +1.51% | -2.14% | 27.47 B USD | ||
| 47 |  MTD Mettler-Toledo International | 1340.36 USD | +1.02% | +6.13% | +12.40% | +26.42% | 27.24 B USD | ||
| 48 |  RVMD Revolution Medicines, Inc. Common Stock | 136.3000 USD | +41.35% | +42.71% | +41.10% | +146.03% | 27.01 B USD | ||
| 49 |  BIIB Biogen Inc. Common Stock | 176.37 USD | +1.97% | +2.42% | -3.50% | +51.87% | 25.88 B USD | ||
| 50 |  VEEV Veeva Systems Inc. | 156.6200 USD | +3.43% | -9.76% | -12.87% | -46.91% | 25.58 B USD | ||
| 51 |  UTHR United Therapeutics Corp | 577.63 USD | +1.03% | +3.64% | +7.62% | +102.50% | 25.32 B USD | ||
| 52 |  DXCM DexCom, Inc. | 63.12 USD | -1.41% | +0.03% | -2.67% | -6.27% | 24.29 B USD | ||
| 53 |  HUM Humana Inc. | 197.76 USD | +2.91% | -1.61% | +18.26% | -33.35% | 23.85 B USD | ||
| 54 |  BNTX BioNTech SE American Depositary Share | 96.70 USD | +1.26% | +7.62% | +5.11% | -2.30% | 23.21 B USD | ||
| 55 |  STE STERIS plc | 223.64 USD | +0.48% | +2.03% | +2.88% | +0.39% | 21.93 B USD | ||
| 56 |  LH Labcorp Holdings Inc. | 263.7500 USD | +1.07% | -5.10% | -1.32% | -5.51% | 21.73 B USD | ||
| 57 |  DGX Quest Diagnostics Inc. | 191.76 USD | +0.13% | -3.82% | -4.95% | +16.47% | 21.07 B USD | ||
| 58 |  RPRX Royalty Pharma plc Class A Ordinary Shares | 48.4300 USD | +1.11% | +3.04% | +5.67% | +29.98% | 20.82 B USD | ||
| 59 |  ROIV Roivant Sciences Ltd. Common Shares | 28.9500 USD | +2.62% | +4.02% | +1.60% | +58.11% | 20.72 B USD | ||
| 60 |  MRNA Moderna, Inc. Common Stock | 50.68 USD | -0.55% | +4.07% | -5.09% | +87.84% | 20.02 B USD |
Nouvelles Healthcare Stocks
Cellectis conserve sa note de surperformance grâce à sa plateforme allogénique
Harrow: Probably A Short-Term Market Overreaction (NASDAQ:HROW)
US stock futures climb as traders cling to de-escalation hopes, await earnings
Company News for Apr 14, 2026
Asgard Therapeutics nomme Wolfram Brugger directeur médical
Grainger nomme Fiona Muldoon au poste d’administratrice non exécutive
Allogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line Consolidation Large B-Cell Lymphoma - Slideshow (NASDAQ:ALLO) 2026-04-14
Gainers Healthcare Stocks
 QNCX Quince Therapeutics, Inc. Common Stock | 1.41 | +907.14% |
 AKAN Akanda Corp. Common Shares | 3.01 | +377.78% |
 RVMDW Revolution Medicines, Inc. Common Stock | 4.4100 | +123.86% |
 NRXPW NRX Pharmaceuticals, Inc. Common Stock | 0.0120 | +87.50% |
 VRAX Virax Biolabs Group Limited Ordinary Shares | 0.17 | +70.00% |
RVMD Revolution Medicines, Inc. Common Stock | 136.3000 | +41.35% |
 GCTK GlucoTrack, Inc. Common Stock | 0.8780 | +32.11% |
 HURA TuHURA Biosciences, Inc. Common Stock | 2.87 | +26.43% |
Losers Healthcare Stocks
 REPL Replimune Group, Inc. | 1.70 | -64.29% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 ONCO Onconetix, Inc. Common Stock | 0.8000 | -26.61% |
 XAIR Beyond Air, Inc. Common Stock | 0.63 | -18.18% |
 QSIAW Quantum-Si Incorporated Class A Common Stock | 0.0900 | -17.20% |
 ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.56 | -15.89% |
 CLGN CollPlant Biotechnologies Ltd Ordinary Shares | 0.32 | -15.79% |
 BFRIW Biofrontera Inc. Common Stock | 0.0400 | -15.61% |